The Latest Breaking News from ELV

Markets will likely remain extremely volatile ahead of the November Consumer Price Index (CPI) report and the Fed’s December policy decisions. Overall, the odds of the economy sliding into a recession are increasing. Given the uncertain economic backdrop, we think it could be wise to invest in fundamentally strong stocks…

Due to the macroeconomic and geopolitical concerns, many fundamentally strong stocks are trading much below their 52-week highs. With inflation easing and the Fed hinting at a slowdown in the pace of rate increases, investors could look to capitalize on the positive sentiment by buying fundamentally strong stocks, Lockheed Martin…

Someone with a lot of money to spend has taken a bullish stance on Elevance Health (NYSE:ELV). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Despite the market’s massive decline since the beginning of the year on concerns over macroeconomic and geopolitical issues, Elevance Health (ELV), Waste Management (WM), and Coca-Cola FEMSA (KOF) continued to soar and are currently trading above their moving averages. Since these stocks are expected to maintain their momentum based on…

Amid the ongoing economic turbulence, sectors like healthcare, which enjoy inelastic demand and can pass on an increase in cost to end consumers, make a good investment option. Moreover, rising chronic diseases, an aging population, and increased healthcare spending should drive the sector’s growth. So, it could be the right…

Healthcare company Elevance Health (ELV) reported solid revenue growth in the last reported quarter. While the stock trades at a discount to its peers, analysts expect the company’s financials to improve. So, let’s evaluate if it would be wise to buy the stock now. Read on.

Healthcare company Elevance Health (ELV) reported solid revenue growth in the last reported quarter. While the stock trades at a discount to its peers, analysts expect the company’s financials to improve. So, let’s evaluate if it would be wise to buy the stock now. Read on.

Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 12.12% on an annualized basis producing an average annual return of 22.8%. Currently, Elevance Health has a market capitalization of $115.15 billion.